Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium-Reference-Cited by-同舟云学术

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

Published:2022-01 Issue: Volume:35 Page:59-67
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Olivier Jonathan^ORCID,Li Weiyu,Nieboer Daan,Helleman Jozien,Roobol Monique,Gnanapragasam Vincent,Frydenberg Mark,Sugimoto Mikio,Carroll Peter,Morgan Todd M.,Valdagni Riccardo,Rubio-Briones Jose,Robert Grégoire,Stricker Phillip,Hayen Andrew,Schoots Ivo,Haider Masoom,Moore Caroline M.,Denton Brian,Villers Arnauld,Trock Bruce,Ehdaie Behfar,Carroll Peter,Filson Christopher,Logothetis Christopher,Morgan Todd,Klotz Laurence,Pickles Tom,Hyndman Eric,Moore Caroline M,Gnanapragasam Vincent,Van Hemelrijck Mieke,Dasgupta Prokar,Bangma Chris,Roobol Monique,Villers Arnauld,Robert Grégoire,Semjonow Axel,Rannikko Antti,Valdagni Riccardo,Perry Antoinette,Hugosson Jonas,Rubio-Briones Jose,Bjartell Anders,Hefermehl Lukas,Lui Shiong Lee,Frydenberg Mark,Stricker Phillip,Sugimoto Mikio,Ha Chung Byung,van der Kwast Theo,Hulsen Tim,van der Linden Wim,Ruwe Boris,van Hooft Peter,Steyerberg Ewout,Nieboer Daan,Denton Brian,Hayen Andrew,Boutros Paul,Guo Wei,Benfante Nicole,Cowan Janet,Patil Dattatraya,Park Lauren,Ferrante Stephanie,Mamedov Alexandre,LaPointe Vincent,Crump Trafford,Stavrinides Vasilis,Kimberly-Duffell Jenna,Santaolalla Aida,Nieboer Daan,Olivier Jonathan,Rancati Tiziana,Ahlgren Helén,Mascarós Juanma,Löfgren Annica,Lehmann Kurt,Han Lin Catherine,Cusick Thomas,Hirama Hiromi,Suk Lee Kwang,Jenster Guido,Auvinen Anssi,Bjartell Anders,Haider Masoom,van Bochove Kees,Kouspou Michelle,Paich Kellie,Bangma Chris,Roobol Monique,Helleman Jozien

Funder

Movember Foundation

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Active surveillance for prostate cancer: a narrative review of clinical guidelines;Bruinsma;Nat Rev Urol,2016

2. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study);Lam;Eur Urol,2019

3. Magnetic resonance imaging targeted biopsy improves selection of patients considered for active surveillance for clinically low risk prostate cancer based on systematic biopsies;Ouzzane;J Urol,2015

4. Randomized study of systematic biopsy versus magnetic resonance imaging and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year postbiopsy follow-up;Klotz;Eur Urol,2020

5. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10 years;The French Journal of Urology;2024-03

2. Détection précoce du cancer de la prostate : vers un nouveau paradigme ?;Progrès en Urologie;2023-12

3. The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review;American Journal of Roentgenology;2023-11

4. Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program;Prostate Cancer and Prostatic Diseases;2023-10-12

5. Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-10